ES2137172T3 - Vacunas antitumorales que comprenden celulas transfectadas con il-6. - Google Patents

Vacunas antitumorales que comprenden celulas transfectadas con il-6.

Info

Publication number
ES2137172T3
ES2137172T3 ES92203217T ES92203217T ES2137172T3 ES 2137172 T3 ES2137172 T3 ES 2137172T3 ES 92203217 T ES92203217 T ES 92203217T ES 92203217 T ES92203217 T ES 92203217T ES 2137172 T3 ES2137172 T3 ES 2137172T3
Authority
ES
Spain
Prior art keywords
antitumoral
transfected cells
vaccines including
patient
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92203217T
Other languages
English (en)
Inventor
Lea Eisenbach
Angel Porgador
Michael Feldman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Application granted granted Critical
Publication of ES2137172T3 publication Critical patent/ES2137172T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001136—Cytokines
    • A61K39/00114—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UNA VACUNA ANTITUMORES QUE INCLUYE CELULAS EN LAS QUE SE HA INTRODUCIDO UN GEN QUE CODIFICAD LA IL-6 HUMANA. UN METODO PARA EL TRATAMIENTO DE UN PACIENTE QUE PADECE CANCER PARA PREVENIR Y/O INHIBIR EL DESARROLLO DE LA METASTASIS MEDIANTE LA ADMINISTRACION AL PACIENTE DE LA VACUNA ANTITUMORES QUE INCLUYE LAS CELULAS ARRIBA MENCIONADAS.
ES92203217T 1991-10-22 1992-10-20 Vacunas antitumorales que comprenden celulas transfectadas con il-6. Expired - Lifetime ES2137172T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL9982191A IL99821A (en) 1991-10-22 1991-10-22 Antitumor vaccines comprising cells transfected with a gene encoding human il-6

Publications (1)

Publication Number Publication Date
ES2137172T3 true ES2137172T3 (es) 1999-12-16

Family

ID=11062992

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92203217T Expired - Lifetime ES2137172T3 (es) 1991-10-22 1992-10-20 Vacunas antitumorales que comprenden celulas transfectadas con il-6.

Country Status (8)

Country Link
EP (1) EP0538952B1 (es)
AT (1) ATE183101T1 (es)
CA (1) CA2081043C (es)
DE (1) DE69229768T2 (es)
DK (1) DK0538952T3 (es)
ES (1) ES2137172T3 (es)
GR (1) GR3031785T3 (es)
IL (1) IL99821A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0599077A3 (en) * 1992-10-29 1994-11-23 Yeda Res & Dev Antimetastatic vaccine.
PL190445B1 (pl) * 1995-05-15 2005-12-30 Akademia Medyczna Im K Marcink Genetyczna szczepionka przeciwrakowa
CA2229543A1 (en) 1995-08-18 1997-02-27 Sloan-Kettering Institute For Cancer Research Heat shock protein-based vaccines and immunotherapies
US6761892B1 (en) 1995-08-18 2004-07-13 Sloan-Kettering Institute For Cancer Research Heat shock protein-based vaccines and immunotherapies
US6277368B1 (en) 1996-07-25 2001-08-21 The Regents Of The University Of California Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
US6087174A (en) * 1996-12-26 2000-07-11 Johns Hopkins University, School Of Medicine Growth medium for primary pancreatic tumor cell culture
AU8392898A (en) * 1997-07-14 1999-02-10 Powerject Vaccines, Inc. Method of dna vaccination using dna encoding antigen and encoding il6
US7420037B2 (en) 2003-02-13 2008-09-02 Antigenics Inc. Heat shock protein-based vaccines and immunotherapies
US7309491B2 (en) 2003-04-11 2007-12-18 Antigenics Inc. Heat shock protein-based vaccines and immunotherapies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3922444A1 (de) * 1988-03-01 1991-01-10 Deutsches Krebsforsch Virusmodifizierte tumorvakzine fuer die immuntherapie von tumormetastasen
CA2091346C (en) * 1990-09-14 2007-04-24 Philip Frost Methods and compositions for genetic therapy and potentiation of anti-tumor immunity

Also Published As

Publication number Publication date
IL99821A (en) 1996-07-23
ATE183101T1 (de) 1999-08-15
DE69229768T2 (de) 2000-05-31
DK0538952T3 (da) 2000-03-13
CA2081043C (en) 2006-01-10
GR3031785T3 (en) 2000-02-29
CA2081043A1 (en) 1993-04-23
EP0538952B1 (en) 1999-08-11
EP0538952A1 (en) 1993-04-28
DE69229768D1 (de) 1999-09-16
IL99821A0 (en) 1992-08-18

Similar Documents

Publication Publication Date Title
CY1106798T1 (el) Ανθρωπινα μεσεγχυματικα βλαστοκυτταρα απο περιφερειακο αιμα
DK85786D0 (da) Biologisk aktive fragmenter af human antihaemofilisk faktor og fremgangsmaade til fremstilling deraf
AR004445A1 (es) Una composicion inmunogenica, una dosis unitaria, un metodo para producir la composicion, un kit para producir la composicion, una poblacion de celulas,uso de dicha poblacion celular y una preparacion combinada
CY1121113T1 (el) Θεραπεια της νοσου ρομρε
DK153920C (da) Toert, pulverformigt allergenmateriale og fremgangsmaade til fremstilling deraf
ES2144426T3 (es) Terapia genica linfoquimica del cancer en combinacion con antigenos tumorales.
EP0957903A4 (en) PHARMACEUTICAL PREPARATIONS AND PROCEDURE
KR930702026A (ko) 자기항원의 경구 투여에 의한 자기면역 질병의 치료
ES2000428T3 (es) Procedimiento para producir un medicamento para el tratamiento de la enfermedad de alzheimer, que contiene galantamina, y dispositivo medico correspondiente.
MXPA03001634A (es) Polipeptido tumoral cripto.
HUP0104235A2 (hu) Parazitaellenes készítmények
DE69030880T2 (de) Zusammensetzung zur Stimulierung des Immunsystems
AR031250A1 (es) Composiciones y metodos para la terapia y el diagnostico del cancer de pulmon
CO4440631A1 (es) Vacunacion in ovo contra la coccidiosis
BR0317064A (pt) Administração de células dentrìticas parcialmente amadurecidas in vitro para o tratamento de tumores
EE200200565A (et) Vaskulaarse kahjustava toimega kombinatsioonravi
ES2137172T3 (es) Vacunas antitumorales que comprenden celulas transfectadas con il-6.
ATE512668T1 (de) Allogenes tumortherapeutikum
HU213677B (en) Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
DK0737069T3 (da) Deuterede aktive stoffer til transdermal administrering
EP1401474A4 (en) METHOD FOR TRIGGERING A CONTINUOUS IMMUNE RESPONSE
ES2086526T3 (es) Aplicacion medicinal de m-csf.
ATE50792T1 (de) Herstellung von plasmid-dns und produkte davon.
PT925064E (pt) 5-androsteno-3beta,17alfa-diol como um inibidor do crescimento tumoral
McGrath et al. Effects of imipramine and phenelzine on plasma PEA levels.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 538952

Country of ref document: ES